Overview

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Status:
RECRUITING

Trial end date:
2026-12-09

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.

Phase:

PHASE1

Details

Lead Sponsor:

Incyte Corporation